The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $81.16

Today's change-0.24 -0.29%
Updated January 24 12:35 PM EST. Delayed by at least 15 minutes.
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $81.16

Today's change-0.24 -0.29%
Updated January 24 12:35 PM EST. Delayed by at least 15 minutes.

Vertex Pharmaceuticals Inc down (U.S.)$0.24

Vertex Pharmaceuticals Inc is lower today, dropping (U.S.)$0.24 or 0.29% to (U.S.)$81.16. Over the last five days, shares have lost 0.48% and 14.31% over the last 52 weeks. This security has underperformed the S&P 500 by 33.64% during the last year.

Key company metrics

  • Open(U.S.) $81.42
  • Previous close(U.S.) $81.40
  • High(U.S.) $82.00
  • Low(U.S.) $80.55
  • Bid / Ask(U.S.) $81.14 / (U.S.) $81.20
  • YTD % change+10.17%
  • Volume428,137
  • Average volume (10-day)1,929,411
  • Average volume (1-month)1,824,313
  • Average volume (3-month)1,983,476
  • 52-week range(U.S.) $71.46 to (U.S.) $103.73
  • Beta0.77
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward96.87×
  • Forward PEG1.47×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.90
Updated January 24 12:35 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue414432398418
Total other revenue--------
Total revenue414432398418
Gross profit361387348356
Total cost of revenue53445062
Total operating expense433428412472
Selling / general / administrative10611210597
Research & development272271256310
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0012
Other operating expenses, total1111
Operating income-193-14-54
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-39-18-31-76
Income after tax-40-36-36-75
Income tax, total1185-1
Net income-39-65-42-74
Total adjustments to net income--------
Net income before extra. items-39-65-42-74
Minority interest1-28-61
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-39-65-42-74
Inc. avail. to common incl. extra. items-39-65-42-74
Diluted net income-39-65-42-74
Dilution adjustment--------
Diluted weighted average shares245244244243
Diluted EPS excluding extraordinary itemsvalue per share-0.16-0.26-0.17-0.30
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.16-0.26-0.17-0.30